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In Western Africa, hepatitis B virus (HBV) geno-
type E predominates throughout a vast crescent
spanning from Senegal to Namibia and at least to
the Central African Republic to the East. Although
from most of the eastern parts of sub-Saharan
Africa only limited sets of strains have been
characterized, these belong predominantly to
genotype A. To study how far the genotype E
crescent extends to the East, a larger number of
HBV strains from Rwanda were analyzed. Phylo-
genetic analysis of 45 S fragment sequences
revealed strains of genotypes A (n¼30), D
(n¼10), C (n¼ 4), and B (n¼1). Twelve genotype
A sequences formed a new cluster clearly sepa-
rated from the reference strains of the known sub-
genotypes. Thus, with four genotypes and at least
six sub-genotypes and a new cluster of genotype
A strains, HBV shows an exceptional genetic
variability in this small country, unprecedented
in sub-Saharan Africa. Despite this exceptional
genetic variability, not a single genotype E virus
was found indicating that this country does not
belong to the genotype E crescent, but is east
of an emerging African genotype E/A1 divide.
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INTRODUCTION
Hepatitis B virus (HBV, family Hepadnaviridae,
genus Orthohepadnavirus) causes chronic infections in
more than 350 million people worldwide, killing about
one million per year [WHO, 2000]. In sub-Saharan
Africa, prevalence rates of hepatitis B surface antigen
(HBsAg) are often very high [Pawlotsky et al., 1995;
Kurbanov et al., 2005; Makuwa et al., 2006; Kramvis
and Kew, 2007a]. Apart from the eight recognized
genotypes A–H of HBV [Okamoto et al., 1987; Norder
et al., 1993; Stuyver et al., 2000], a new genotype,
tentatively designated I, has been assigned recently to
strains found in Laos and Vietnam [Jutavijittum et al.,
2007; Tran et al., 2008; Olinger et al., 2008]. Most of the
genotypes exhibit a distinct geographic distribution
[Kimbi et al., 2004; Mulders et al., 2004; Hannoun
et al., 2005; Kurbanov et al., 2005; Makuwa et al., 2006;
Olinger et al., 2006]. In Northern Africa, genotype D
seems to be the most prevalent genotype [Kramvis and
Kew, 2007a]. However, in sub-Saharan Africa the
genetic diversity and genotype distribution of HBV are
somewhat puzzling. Genotype A is dominant in South
Africa, Mozambique, and Kenya [Kramvis and Kew,
2007a]. From most other East African countries only few
sporadic strains have been genotyped so far [Kramvis
et al., 2002; Sugauchi et al., 2003; Kimbi et al., 2004;
Hannoun et al., 2005; Kramvis and Kew, 2007a].
Although genotype A has been observed on all con-
tinents [Kramvis and Kew, 2007b], it is nowhere
genetically as diverse as in Africa, where a variety of
sub-genotypes and variants have been found. Therefore
it has been suggested that genotype A evolved in Africa
before spreading to other parts of the world [Hannoun
et al., 2005]. Nevertheless genotype A is relatively rare
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in many parts of Africa. In fact, in West Africa, where
genotype A is highly diverse genetically, genotype E
is by far the most prevalent genotype. Genotype E
predominates throughout a vast crescent spanning from
Senegal to Namibia [Mulders et al., 2004; Kramvis and
Kew, 2007a] including The Gambia [Dumpis et al.,
2001], Ivory Coast [Suzuki et al., 2003], Ghana [Candotti
et al., 2006], Angola [Kramvis and Kew, 2007a], Mali,
Burkina Faso, Togo, Benin, Nigeria, Central African
Republic, and at least the Western part of the Demo-
cratic Republic of the Congo (DRC) [Mulders et al., 2004;
Olinger et al., 2006; Bekondi et al., 2007]. Except for
Cameroon and Gabon, only a few sporadic but diverse
strains of genotype A were found in West African
countries such as Mali, Burkina Faso, and Nigeria
[Mulders et al., 2004; Olinger et al., 2006]. In Cameroon,
genotype A is relatively frequent, in particular in HIV
carriers [Mulders et al., 2004]. In healthy Bantus and
Pygmies the prevalence of genotypes A and E was
similar (43.5%) [Kurbanov et al., 2005].
In contrast to genotype A, genotype E has a surpris-
ingly low genetic diversity, suggesting a short evolu-
tionary history in Africa. A recent introduction of
genotype E into the general human population is also
compatible with its absence in the Americas despite the
Afro-American slave trade until 200 years ago. How-
ever, its recent introduction would be difficult to
reconcile with its vast spread throughout West and
Southwest Africa and the long evolutionary history of
genotype A in Africa. Thus the geographic distribution
and the relative prevalence of the genotypes are of
considerable interest for understanding the natural
history of HBV in Africa. So far it is not clear how far the
genotype E crescent extends to the east. Furthermore,
for most countries in Eastern Africa little or no genotype
information is available. The first molecular analysis
of a larger number of HBV strains from Rwanda is
described below. In this country east of the Congo
genotype A, including a new variant, dominated and no
genotype E was found.
MATERIALS AND METHODS
Clinical Samples
Four hundred eight serum samples were collected
between 2001 and 2006 from known HIV-positive
women. More than 95% were pregnant and attended
one of three different health care centers in and around
Kigali, Rwanda. The exact age and nationality of the
patients were not known. Blood was drawn after
informed consent and according to national ethical
guidelines. All samples were tested for HBsAg, anti-
HBs, and anti-HBc antibodies using either the Murex
kits (Murex Biotech Limited, Dartford, UK) or the
AxSYM1 test system (Abbott Laboratories), Chicago, IL.
Amplification
DNA was extracted using the QIAamp1 DNA Blood
Mini Kit (Qiagen, Venlo, NL) following the manufac-
turer’s protocol. Either part or the complete genome of
HBV was amplified by two-round PCRs as described
previously [Olinger et al., 2006]. In case only the S
fragment PCR was positive, amplification was repeated
with less stringent conditions (3 mM MgCl2 and an
annealing temperature lowered by 28C).
Sequencing and Phylogenetic Analysis
The positive nested PCR products were purified and
sequenced as described before [Olinger et al., 2006].
Phylogenetic analysis was performed using the MEGA
v3.1 software [Kumar et al., 2004] with the neighbor-
joining and Kimura 2-parameter methods. Distance
calculations were also carried out with MEGA v3.1 using
the pairwise and within group means options. All S
fragment and complete genome sequences were sub-
mitted to EMBL/GenBank/DDBJ under accession num-
bers FM200180-216 and FM199974-81.
RESULTS
Serology and PCR
One hundred fifty one of the 408 samples were HBsAg
positive, 252 were anti-HBc, and 203 anti-HBs positive
(Table I). Eight and 19 samples could not be tested for
anti-HBc and anti-HBs, respectively, due to a shortage
of serum. Fifty-five of the 408 samples (13.5%) were HBV
PCR positive. Thirty-seven of these were from HBsAg
positive individuals, whereas about one third (18/55) of
the HBV strains were obtained from patients with occult
infections (Table I). Eight strains were recovered from
HBsAg positive patients who were negative for both
anti-HBs and anti-HBc.
Sequences and Genotypes
The S fragment was available for all but 10 PCR
positive and for eight samples the complete genome
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Anti-HBs positive 44 4 0 146 9 0 203
Anti-HBs negative 35 60 0 24 67 0 186
Anti-HBs not tested 1 3 4 2 5 4 19
Total 80 67 4 172 81 4 408
PCR positive 24 11 2 14 4 0 55
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sequence was obtained. Phylogenetic analysis of the S
fragment sequences (n¼ 45) revealed that 30 strains
(67%) were of genotype A, 16 of which were of sub-
genotype A1 (Fig. 1a) and the majority of which were
most closely related to a strain from Congo (DQ020002).
Strain 49063 showed the maximal similarity with a
strain from Italy (EF514279). Twelve genotype A
sequences clustered together, but separately from the
reference strains of the different A sub-genotypes. This
new cluster of genotype A was supported by a bootstrap
value of 85. One strain (49057) clustered with sequences
24063 and 24074 from Nigeria, which have previously
been suggested to belong to a new sub-genotype A5
[Olinger et al., 2006]. The status of this group of
sequences still awaits clarification based on full genome
sequences. Another strain (49008), which showed the
highest similarity to strains from Mali (AM180623) and
Gambia (AY934763), grouped with an A3 reference
J. Med. Virol. DOI 10.1002/jmv
Fig. 1. a: Phylogenetic analysis of 45 HBV strains from Rwanda (*) based on 825 nt of the S fragment.
‘‘A5’’ designation according to Olinger et al. [2006]. b: Phylogenetic analysis of eight full genome HBV
strains from Rwanda (*).
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strain. A single strain (49109) belonged to sub-genotype
B4 and was related most closely to sequence AY033072
and to AB031266 from Vietnam; four strains belonged to
sub-genotype C2, which showed the maximal similarity
to EU075342, EU075336, and EU075334 from China
and 10 viruses (22%) grouped with genotype D.
The latter were either sub-genotyped as D3 (n¼7), of
which two different lineages were observed and which
were most closely related to European strains (e.g.,
EU414141 and EU686583), or D4 (n¼3) strains (Fig. 1a)
which were most similar to AB048703 from Australia
and AB033559 from Papua New Guinea. All strains for
which the full genome was available belonged to sub-
genotype A1 (Fig. 1b) which was fully consistent with
the phylogeny based on their S fragment only.
Genetic Variability of Genotypes
and Sub-Genotypes
The maximal genetic distance between the S fragment
sequences of the 45 Rwanda strains was 8.36%.
Genotype A sequences showed a maximal genetic
distance of 4.64% (mean 2.48%), which was about twice
as high as the distance between genotype D sequences
(maximum 2.18%, mean 1.10%). Among the sub-geno-
types and variants the maximal genetic diversity was
highest within the new group of genotype A sequences,
with 2.74% (mean 1.35%), followed by A1 with 2.00%
(mean 0.78%), D3 with 1.15% (mean 0.59%), D4 with
0.37% (mean 0.20%), and C2 with 0.36% (mean 0.18%).
By BLAST search, the closest relatives to a sequence
belonging to the new cluster of genotype A (45059) were
strains AY934764 with a genetic distance of 2.09% and
AM180623 with 2.22%. The maximal diversity among
the eight A1 strains over the complete genome was
1.73% (mean 0.98%).
Nucleotide and Amino Acid Sequence Analysis
Fourteen strains showed ambiguous nucleotides in up
to seven positions (49033) in a region of 825 nucleotides
of the S fragment. With one exception (49224) ambi-
guous nucleotides were detected in all full genome
sequences (genotype A1) with a maximum of nine in
sample 49263. No insertions or deletions were found.
Three strains (49045, 49065, 49148) showed internal
stop codons in the S gene. In the region of the a
determinant (amino acids 124–147) [Zuckerman and
Zuckerman, 2003], two of the most frequent vaccine- and
drug-selected amino acid mutations [Table XIV.4, Car-
man et al., 2005] were observed in some strains: D144A
(45024, 49026, 49244, 49262) and G145R (49008).
Mutations in these positions are often associated with
anti-HBs immune pressure [Carman et al., 2005]. While
all D144A mutants were of sub-genotype A1, the G145R
mutant belonged to sub-genotype A3. All but one (45024)
of the samples with these mutations, were from patients
who had received standard anti-retroviral therapy
with stavidine, lamivudine, and nevirapine for at least
6 months. Two patients were HBsAg positive (49244 and
49262), while the other three were HBsAg negative, but
anti-HBc positive. Two complete genome sequences
were obtained from patients with occult infections
(45082 and 45088), but no mutations typical for both
strains were found.
DISCUSSION
This study shows a surprising and for sub-Saharan
Africa exceptionally high diversity of HBV strains. Four
different genotypes (A, B, C, and D), three of which had a
prevalence above 8%, and at least six different sub-
genotypes (A1, A3, B4, C2, D3, and D4) were found
within and around Kigali, the capital of the small East
African country Rwanda. Only the vast Republic of
South Africa seems to have a similar HBV geno- and sub-
genotype diversity. Most other sub-Saharan countries
have essentially two genotypes: A and E. Except for
Cameroon, where both genotypes have a similar
prevalence [Kurbanov et al., 2005], either one of the
two genotypes dominates.
In Rwanda, two-thirds of the strains belonged to
genotype A. This genotype seems to dominate in all East
African countries for which larger sets of HBV strains
have been characterized such as South Africa, Mozam-
bique, and Kenya [Kramvis and Kew, 2007a]. The
majority of genotype A strains (16/30) in Rwanda
belonged to A1, the main ‘‘African’’ A sub-genotype.
Interestingly, this sub-genotype was also found in most
countries along the eastern coast of Africa from the
Republic of South Africa to the Horn of Africa, although
only few sequences are available from most of these
countries [Kramvis and Kew, 2007a]. Thus our results
provide further evidence of a dominance of A1 sub-
genotype when moving towards Eastern Africa.
One A strain clustered with strains of sub-genotype
A3, which was so far found, for example, in Cameroon,
DRC, Gabon, and the Gambia [Mulders et al., 2004;
Hannoun et al., 2005; Makuwa et al., 2006]. Another
single strain was most closely related to strains from
Nigeria, which, have previously been suggested to form
a provisional new sub-genotype (‘‘A5’’) [Olinger et al.,
2006]. Forty percent of genotype A strains in Rwanda,
however, belonged to a separate cluster supported by a
high bootstrap values and distinct from all known
genotype A sub-genotypes. At least on the S gene the
between-group mean genetic distance from the closest
sub-genotype (A3, six published sequences from Came-
roon and Gabon) was 2.11%. The maximal genetic
distance of 3.01% was observed between strains
AM184126 from Gabon and 49291. The phylogenetic
characteristics and the geographic confinement of the
large number of strains may well be suggestive of a new
sub-genotype which can, however, only be confirmed by
full-length sequences. In any case, these strains from
Rwanda extend further the genetic variability of
genotype A, possibly beyond sub-genotype A3 [Mulders
et al., 2004] and the other new variants found in West
Africa (‘‘A4’’ and ‘‘A5’’) [Olinger et al., 2006]. Interest-
ingly, except for A1, A2, and to a lesser extent A3 strains,
the other genotype A variants seem very confined
J. Med. Virol. DOI 10.1002/jmv
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geographically. This pattern is confirmed further by the
distinct variant of genotype A found in Rwanda. The
high genetic diversity of genotype A, which is higher in
Africa than anywhere else suggests that this genotype
has a long evolutionary history in Africa and probably
has spread from Africa to other parts of the world
[Hannoun et al., 2005]. On the other hand the low
prevalence and the geographical limitation of the new
genotype A variants [Olinger et al., 2006] in Africa
suggest their compartmentalized evolution in different
regions in Africa. This study provides important
evidence to support this view. Thus, genotype A is in
contrast to the high prevalence and the low genetic
diversity of genotype E in Western Africa.
Another notable result is the conspicuous absence of
genotype E from Rwanda. In the West-African bulge and
along the West-African coastal countries genotype E
is the most prevalent genotype. While at least in the
Western part of Congo the majority of the few strains
reported belonged to genotype E [Mulders et al., 2004],
not a single strain of this genotype was found in
neighboring Rwanda. Thus, Rwanda is not part of the
vast African genotype E crescent. The geographical
location of the country provides further important
evidence of a clear genotype E/A1 divide between West
and East Africa with Rwanda on the east of this divide,
and running through Congo. Thus our results also
suggest that east of the genotype E/A1 divide pockets
of genotype A variants can be found similar to those
described in Western Africa [Olinger et al., 2006]. While
the diversity of genotype A viruses found in Africa
continues to increase, this is not the case for genotype E,
which has no sub-genotypes.
Interestingly, more than 20% of the sequences from
Rwanda belong to sub-genotypes D3 and D4 which
otherwise in Africa were only reported sporadically
from, for example, South Africa [Kimbi et al., 2004; Kew
et al., 2005], Ghana (D4) [Candotti et al., 2006], and
Somalia (D4) [Norder et al., 2004]. Genotype B and C
strains were only reported rarely from African countries
such as South Africa [Bowyer et al., 1997] and Egypt
[Zekri et al., 2007] and now also from Rwanda where C2
strains represent nearly 9% of all strains. This sub-
genotype is normally observed in Far Eastern countries
[Huy et al., 2004; Chan et al., 2005; Tanaka et al., 2005]
and has to our knowledge not yet been reported from any
other African country.
Despite the observed co-circulation of several HBV
genotypes, no obvious mixed infection of genotypes
was detected based on the electropherograms of the S
fragment and the complete genome sequences. Although
several samples showed ambiguous nucleotides, their
number and positions indicated the presence of quasi-
species rather than mixed infections.
One hundred fifty one samples were positive for
HBsAg, but surprisingly only about one quarter of these
(37/151) were PCR positive. About two-thirds of the
latter (25/37) were from patients that were positive for
at least one antibody (anti-HBs, anti-HBc) and only
eight were PCR positive among the HBsAg positive and
antibody double-negative (8/60). This suggests that in
particular in the latter group a number of samples were
false positive in the HBsAg ELISA. Frequent false-
positivity in HBsAg ELISA tests has been reported
before in Rwanda [Pirillo et al., 2007], but also during
pregnancy [Weber et al., 1999]. Nevertheless, eight
HBsAg positive patients were PCR positive but had
no antibodies, a constellation which may be explained
by either early infection or HIV-associated immune-
suppression (or a combination of both). Among the 172
HBsAg negative patients with anti-HBc 14 had occult
infections. Among the four weak PCR positives in
HBsAg and anti-HBc double negative samples, three
were also anti-HBs negative, a pattern compatible with
very early acute infection. Antiretroviral treatments
of the patients may have further complicated the
serological status of this cohort. No association between
genotype and serological pattern could be observed.
In summary, Rwanda does not belong to the genotype
E crescent, but is east of an African genotype E/A1
divide. Strains from Rwanda show an exceptional
genetic variability, unprecedented in sub-Saharan
Africa, with four genotypes, at least six sub-genotypes
and a new cluster of genotype A strains.
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